Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension

被引:8
作者
Sanchez-Gloria, Jose L. [1 ,2 ]
Osorio-Alonso, Horacio [3 ]
Arellano-Buendia, Abraham S. [3 ]
Carbo, Roxana [4 ]
Hernandez-Diazcouder, Adrian [2 ,5 ]
Guzman-Martin, Carlos A. [1 ,2 ]
Rubio-Gayosso, Ivan [1 ]
Sanchez-Munoz, Fausto [1 ,2 ]
机构
[1] Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad, Mexico City 11340, DF, Mexico
[2] Inst Nacl Cardiol Ignacio Chavez, Dept Inmunol, Mexico City 14080, DF, Mexico
[3] Inst Nacl Cardiol Ignacio Chavez, Dept Fisiopatol Cardiorenal, Mexico City 14080, DF, Mexico
[4] Inst Nacl Cardiol Ignacio Chavez, Dept Biomed Cardiovasc, Mexico City 14080, DF, Mexico
[5] Univ Autonoma Metropolitana Iztapalapa, Posgrad Biol Expt, Mexico City 09340, DF, Mexico
关键词
pulmonary arterial hypertension; nutraceuticals; antihypertensive; antioxidant; antiproliferative; anti-inflammatory; NITRIC-OXIDE SYNTHASE; SOLUBLE GUANYLATE-CYCLASE; ACTIVATED PROTEIN-KINASE; ENDOTHELIN RECEPTOR ANTAGONISTS; RAT SMALL-INTESTINE; CHLOROGENIC ACID; ELLAGIC ACID; L-ARGININE; ESTROGEN-RECEPTOR; IN-VITRO;
D O I
10.3390/ijms21144827
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death. Although many drugs are available for the treatment of this condition, it continues to be life-threatening, and its long-term treatment is expensive. On the other hand, many natural compounds present in food have beneficial effects on several cardiovascular conditions. Several studies have explored many of the potential beneficial effects of natural plant products on PAH. However, the mechanisms by which natural products, such as nutraceuticals, exert protective and therapeutic effects on PAH are not fully understood. In this review, we analyze the current knowledge on nutraceuticals and their potential use in the protection and treatment of PAH, as well as whether nutraceuticals could enhance the effects of drugs used in PAH through similar mechanisms.
引用
收藏
页码:1 / 35
页数:35
相关论文
共 50 条
  • [1] Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
    Segura-Ibarra, Victor
    Wu, Suhong
    Hassan, Nida
    Moran-Guerrero, Jose A.
    Ferrari, Mauro
    Guha, Ashrith
    Karmouty-Quintana, Harry
    Blanco, Elvin
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [2] Macitentan for the treatment of pulmonary arterial hypertension
    Kholdani, Cyrus A.
    Fares, Wassim H.
    Trow, Terence K.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 665 - 673
  • [3] Medical treatment update on pulmonary arterial hypertension
    Enderby, Cher Y.
    Burger, Charles
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (05) : 264 - 272
  • [4] Development of macitentan for the treatment of pulmonary arterial hypertension
    Selej, Mona
    Romero, Alain J.
    Channick, Richard N.
    Clozel, Martine
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN 2014, 2015, 1358 : 68 - 81
  • [5] TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Gutierrez, Fernando
    Gonzalez, Itamar
    Sanchez Jose, Luis
    Tevar, Enrique
    Vina, Ma Micaela
    Merino, Javier
    ATENCION FARMACEUTICA, 2010, 12 (01): : 39 - 46
  • [6] Management of Pulmonary Arterial Hypertension
    McLaughlin, Vallerie V.
    Shah, Sanjiv J.
    Souza, Rogerio
    Humbert, Marc
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (18) : 1976 - 1997
  • [7] Treatment of pulmonary arterial hypertension
    Roman, Antonio
    Lopez-Meseguer, Manuel
    Domingo, Enric
    MEDICINA CLINICA, 2015, 144 (12): : 566 - 570
  • [8] Future Perspectives for the Treatment of Pulmonary Arterial Hypertension
    Ghofrani, Hossein A.
    Barst, Robyn J.
    Benza, Raymond L.
    Champion, Hunter C.
    Fagan, Karen A.
    Grimminger, Friedrich
    Humbert, Marc
    Simonneau, Gerald
    Stewart, Duncan J.
    Ventura, Carlo
    Rubin, Lewis J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) : S108 - S117
  • [9] Controlled Release Inhalable Polymeric Microspheres for Treatment of Pulmonary Arterial Hypertension
    Saigal, Aparna
    Ng, Wai Kiong
    Tan, Reginald B. H.
    Chan, Sui Yung
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (40) : 5868 - 5876
  • [10] Update: Preclinical developments of the treatment of pulmonary arterial hypertension
    Janssen, W.
    Ghofrani, H. A.
    Weissmann, N.
    Grimminger, F.
    Schermuly, R. T.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S157 - S159